Julie Martin - Publications, H-index & Citations

Julie Martin

medicine

39H指数

106论文数

3.6W被引数

收录论文 17

发表时间

Glycan analysis of serum and breast tissue identifies potential biomarkers of cancer subtype and severity 血清和乳腺组织中糖链分析鉴定癌症亚型和严重程度的潜在生物标志物

BMC Cancer

IF3.4

2026-04-11

OAAI

Nourine A.H. Kamili; Clay Elliot; Avery Funkhouser; Isam Alam; Julie C. Martin; Homayoun Valafar; Yi Lasanajak; Xuezheng Song; Connie M. Arthur; W. Jeffery Edenfield; Anna V. Blenda

Knowledge Architecture for Race and Ethnic Group Defining in Learning Health Systems 学习健康系统中种族和族裔群体定义的知识架构

Learning Health Systems

IF2.6

2026-02-26

OAAI

Matthew F. Hudson; Virginia M. S. van Staden; Alicia M. Oostdyk; Julie C. Martin

Comparative Analysis of Manual ELISA and Ella, an Automated Instrument for ELISA, in Measuring Serum Galectin-3 Levels in Breast Cancer Patient Samples 比较手动ELISA与Ella（一种自动化ELISA仪器）在测量乳腺癌患者样本血清Galectin-3水平中的分析研究

Cancers 2025, Vol. 17, Page 3206

IF4.4

2025-10-01

OAAI

Ella G. Markalunas; Shannon E. Harold; David H. Arnold; Julie C. Martin; W. Jeffery Edenfield; Anna V. Blenda

Evaluation of genetic mutations in non-small cell lung cancer patients

CANCER RESEARCH

IF16.6

2024-03-22

PREAI

Rothstein, Miles; Broughton, Phillip; Markalunas, Ella; Funkhouser, Avery; Allen, Lorie; Martin, Julie; Edenfield, W. Jeffery; Blenda, Anna V.

Prisma Health Cancer Institute: Racial Analysis in Cancer Patients Using Molecular, Clinical, and Demographic Data

CANCER RESEARCH

IF16.6

2024-02-01

PREAI

Austin, Brittany K.; Martin, Julie; Edenfield, Jeff; Blenda, Anna

Considering context in area-level socioeconomic status, cancer treatment initiation, and survival

JNCI CANCER SPECTRUM

IF4.1

2023-10-17

OAAI

Hudson, Matthew F.; Oostdyk, Alicia M.; Simmons, Virginia M.; Martin, Julie C.

Potential of galectin7 as differentiating biomarker of lung cancer subtypes

CANCER RESEARCH

IF16.6

2023-04-04

PREAI

Funkhouser, Avery T.; Shealy, Jonah C.; Kesic, Alexandra E.; Blair, Bailey B.; Martin, Julie C.; Arthur, Connie M.; Funk, Christopher R.; Edenfield, W. Jeffery; Blenda, Anna V.

Analysis of cancer patients' molecular and clinical data using artificial intelligence and machine learning approaches

CANCER RESEARCH

IF16.6

2023-04-04

PREAI

Firooz, Ali; Funkhouser, Avery T.; Martin, Julie C.; Edenfield, W. Jeffery; Valafar, Homayoun; Blenda, Anna V.

Examining how social networks influence women and under-represented minority students' pursuit of engineering in university: when, who, and how?

INTERNATIONAL JOURNAL OF STEM EDUCATION

IF8

2023-04-03

OAAI

Wao, Hesborn; Kersaint, Gladis; Smith, Chrystal A. S.; Campbell-Montalvo, Rebecca; Puccia, Ellen; Skvoretz, John; Martin, Julie P.; Lee, Reginald; MacDonald, George

In memory of Jeffrey E. Froyd: a collection of tributes 纪念Jeffrey E. Froyd: 致敬的集合

INTERNATIONAL JOURNAL OF STEM EDUCATION

IF8

2022-11-29

OAAI

Li, Yeping; Kimball, Jorja L.; Ulseth, Ronald; Bates, Rebecca A.; Borrego, Maura; Nite, Sandra B.; Martin, Julie P.; Henderson, Charles R.; Cole, Renee S.; Ruder, Suzanne M.; Lantz, Juliette; Kajfez, Rachel L.; Dringenberg, Emily; Delaine, David A.; Froyd, Cara

Comprehensive Glycomic Profiling of Breast Cancer Patients

FASEB JOURNAL

IF4.2

2022-05-13

PREAI

Funkhouser, Avery; Chaballout, Basil; Goodwin, Jane; Martin, Julie; Edenfield, W. Jeffery; Arthur, Connie M.; Blenda, Anna V.

Non-coding FLT3 Mutation is Associated with Lower Galectin Levels in Breast Cancer Patients

FASEB JOURNAL

IF4.2

2022-05-13

PREAI

Funkhouser, Avery; Blair, Bailey; Goodwin, Jane; Strigenz, Alec; Martin, Julie; Funk, Christopher R.; Edenfield, W. Jeffery; Blenda, Anna V.

Efficacy of therapeutic plasma exchange in the treatment of penn class 3 and 4 cytokine release syndrome complicating COVID-19

RESPIRATORY MEDICINE

IF3.1

2020-12-01

OAAI

Gluck, W. Larry; Callahan, Sean P.; Brevetta, Robert A.; Stenbit, Antine E.; Smith, Wesley M.; Martin, Julie C.; Blenda, Anna, V; Arce, Sergio; Edenfield, W. Jeffery

Acute Poststreptococcal Glomerulonephritis: A Manifestation of Immune Reconstitution Inflammatory Syndrome

PEDIATRICS

IF6.4

2012-09-01

PREAI

Martin, Julie; Kaul, Aditya; Schacht, Robert

A phase I trial of PX-12, a small-molecule inhibitor of thioredoxin-1, administered as a 72-hour infusion every 21 days in patients with advanced cancers refractory to standard therapy PX-12的I期试验，一种小分子thioredoxin-1抑制剂，每21天在标准治疗难治性晚期癌症患者中进行72小时输注

INVESTIGATIONAL NEW DRUGS

IF2.7

2011-08-24

PREAI

Ramanathan, Ramesh K.; Stephenson, Joe J.; Weiss, Glen J.; Pestano, Linda A.; Lowe, Ann; Hiscox, Alton; Leos, Rafael A.; Martin, Julie C.; Kirkpatrick, Lynn; Richards, Donald A.

Disabled-2 downregulation promotes epithelial-to-mesenchymal transition

BRITISH JOURNAL OF CANCER

IF6.8

2010-11-09

OAAI

Martin, J. C.; Herbert, B-S; Hocevar, B. A.

An Open-Label Clinical Trial Evaluating Safety and Pharmacokinetics of Two Dosing Schedules of Panitumumab in Patients with Solid Tumors

CLINICAL COLORECTAL CANCER

IF3.2

2009-01-01

PREAI

Stephenson, Joe J.; Gregory, Charles; Burris, Howard; Larson, Tim; Verma, Udit; Cohn, Allen; Crawford, Jeffrey; Cohen, Roger B.; Martin, Julie; Lum, Peggy; Yang, Xinqun; Amado, Rafael G.

研究方向